- At: 2009 FIP Congress in Istanbul (Turkey)
- Type: Presentation
- By: HARTMAN, Neil Godfried (St Bartholomew's Hospital, London, United Kingdom)
There has been a sizeable increase in the number of developed radiopharmaceuticals in the past decade, although several reliable agents have also been withdrawn from the market. This discussion will focus on 4 pertinent areas: 1. The changes to medicines legislation (emphasis on the EU), and its impact on radiopharmaceutical development. 2. A.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.